Characteristics

Breakdown of Factors

Age Group ≤ 45 years

N = 64

Age Group > 45 years

N = 65

p value

Age (years)

Median (IQR)

36 years

(27, 41)

56 years

(50, 60)

<0.001

FIGO Stage

N (%)

Stage I

Stage II

Stage III

Stage IV

20 (31.2%)

3 (4.7%)

32 (50.0%)

9 (14.1%)

10 (15.4%)

6 (9.2%)

39 (60.0%)

10 (15.4%)

0.167

CA125 at diagnosis

N (%)

≤200

>200

10 (26.3%)

28 (73.7%)

2 (5.9%)

32 (94.1%)

0.044

Age of menarche (years), median (IQR)

12 (12, 13)

12 (12, 13)

0.935

Age of menopause (years), median (IQR)

41 (40, 45)

50 (45, 52)

<0.001

Menopausal n (%)

16 (25%)

64 (98.46%)

<0.001

Timing of surgery—Days from diagnosis for PDS & staging

Days from last chemo for IDS

*PDS

*IDS

Staging laparotomy

18 (28.1%)

22 (34.4%)

24 (37.5%)

20 (30.8%)

26 (40.0%)

19 (29.2%)

0.603

Follow-up (months, median (IQR)

12 (6, 42)

6 (3, 18)

0.016)

Interval between diagnosis and surgery (days), median (IQR)

46.50 (28, 94.75)

52 (27, 92)

0.815

Survival N (%)

Alive

Dead of Disease

27 (43.5%)

35 (56.5%

12 (20.0%)

48 (80%)

0.005

Histopathology

N (%)

Serous

Mucinous

Other

48 (75%)

11 (17.2%)

5 (7.8%)

54 (83.1%)

2 (3.1%)

9 (13.8%)

0.021